Search

Search by keyword or author

Comprehensive Insights into Lipid Nanocarriers: Preparation, Characterization and Applications

Home > 2025, Vol. 13 No. 02 > Comprehensive Insights into Lipid Nanocarriers: Preparation, Characterization and Applications
Published: August 4, 2026
Download PDF
Download HTML

Authors

Ravi Goyal, Gurpreet Kaur, Sumit Sharma, Deepika Raina, Nitin Chitranshi

DOI Number
https://doi.org/10.15415/jptrm.2025.132006
Keywords
Colloidal drug carrier, Controlled release, Enhanced bioavailability, Lipid matrix, Lipid nano carriers, Targeted drug delivery system

Abstract

Background: Lipid nanocarriers have emerged as a novel alternative to traditional drug delivery systems such as emulsions, liposomes, and microparticulate systems. These are spherical nano-sized (1–1000 nm) colloidal carriers dispersed in an aqueous surfactant solution. Their biodegradable, biocompatible, and non-toxic nature has led to extensive exploration in clinical medicine for multiple routes of administration, including oral, parenteral, and topical delivery. They offer high stability, large drug-loading capacity, and the ability to deliver both hydrophilic and lipophilic drugs in a targeted and controlled manner.

Purpose: The purpose of this review is to provide a comprehensive overview of lipid nanocarriers, focusing on their fundamental principles, advantages, limitations, preparation methods, and characterization techniques.

Methods: The review compiles and analyzes literature from relevant publications from the last 15 years on lipid nanocarriers, covering their formulation approaches, different preparation techniques, and evaluation parameters used to assess their physicochemical and functional properties.

Results: Lipid nanocarriers demonstrate significant advantages, including enhanced stability, improved drug loading, controlled and targeted drug release, and adaptability to various formulation requirements. Their versatility makes them suitable for applications in pharmaceuticals, vaccines, nutraceuticals, and diagnostic systems.

Conclusions: A comprehensive understanding of lipid nanocarriers can open new avenues in the treatment of multifactorial disorders. Their safety, efficacy, and flexibility position them as promising candidates for advanced drug delivery systems and future therapeutic innovations.

References

  • Agrawal, Y. O., Mahajan, U. B., Mahajan, H. S., & Ojha, S. (2020). Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: Formulation, optimization, characterization, in vitro and in vivo studies. International Journal of Nanomedicine, 15, 4763–4778. https://doi.org/10.2147/IJN.S247007
  • Akiyoshi, K., Kobayashi, S., Shichibe, S., Mix, D., Baudys, M., Kim, S. W., & Sunamoto, J. (1998). Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. Journal of Controlled Release, 54(3), 313–320. https://doi.org/10.1016/S0168-3659(98)00017-0
  • Andreozzi, E., Seo, J. W., Ferrara, K., & Louie, A. (2011). Novel method to label solid lipid nanoparticles with 64Cu for positron emission tomography imaging. Bioconjugate Chemistry, 22(4), 808–818. https://doi.org/10.1021/bc100478k
  • Arbain, R., Othman, M., & Palaniandy, S. (2011). Preparation of iron oxide nanoparticles by mechanical milling. Minerals Engineering, 24(1), 1–9. https://doi.org/10.1016/j.mineng.2010.08.025
  • Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016). Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. European Journal of Pharmaceutical Sciences, 109, 224–235. https://doi.org/10.1016/j.ejpb.2016.10.015
  • Bhandari, R., & Kaur, I. P. (2013). Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. International Journal of Pharmaceutics, 441(1–2), 202–212. https://doi.org/10.1016/j.ijpharm.2012.11.042
  • Bhaskar, K., Anbu, J., Ravichandiran, V., Venkateswarlu, V., & Rao, Y. M. (2009). Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids in Health and Disease, 8(1), 1–15. https://doi.org/10.1186/1476-511X-8-6
  • Bonacucina, G., Perinelli, D. R., Cespi, M., Casettari, L., Cossi, R., Blasi, P., & Palmieri, G. F. (2016). Acoustic spectroscopy: A powerful analytical method for the pharmaceutical field? International Journal of Pharmaceutics, 503(1–2), 174–195. https://doi.org/10.1016/j.ijpharm.2016.03.009
  • Cavalli, R., Caputo, O., & Gasco, M. R. (2000). Preparation and characterization of solid lipid nanospheres containing paclitaxel. European Journal of Pharmaceutics Sciences, 10(4), 305–309. https://doi.org/10.1016/S0928-0987(00)00081-6
  • Chattopadhyay, P., Shekunov, B. Y., Yim, D., Cipolla, D., Boyd, B., & Farr, S. (2007). Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Advanced Drug Delivery Reviews, 59(6), 444–453. https://doi.org/10.1016/j.addr.2007.04.010
  • Chaturvedi, S. P., & Kumar, V. (2012). Production techniques of lipid nanoparticles: A review. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 3(3), 525–541.
  • Chavan, S. S., Ingle, S. G., & Vavia, P. R. (2013). Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonide. Drug Delivery and Translational Research, 3(5), 402–408. https://doi.org/10.1007/s13346-012-0105-z
  • Cunha, S., Forbes, B., Sousa Lobo, J. M., & Silva, A. C. (2021). Improving drug delivery for Alzheimer’s disease through nose-to-brain delivery using nanoemulsions, nanostructured lipid carriers (NLC) and in situ hydrogels. International Journal of Nanomedicine, 16, 4373–4390. https://doi.org/10.2147/IJN.S305851
  • Danaei, M., Dehghankhold, M., Ataei, S., Davarani, F. H., Javanmard, R., Dokhani, A., & Mozafari, M. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nano-carrier systems. Pharmaceutics, 10(2), 1–17. https://doi.org/10.3390/pharmaceutics10020057
  • Dorset, D. L. (1998). X-ray diffraction: A practical approach. Microscopy and Microanalysis, 4(5), 513–515. https://doi.org/10.1017/S143192769800049X
  • Douglas, S. J., & Davis, S. S. (1986). Particle size analysis of colloidal systems by photon correlation spectroscopy. In Targeting of drugs with synthetic systems (pp. 265-276). Boston, MA: Springer US. https://link.springer.com/chapter/10.1007/978-1-4684-5185-6_19
  • Duong, V. A., Maeng, H. J., & Chi, S. C. (2019). Nanostructured lipid carriers containing ondansetron hydrochloride by cold high-pressure homogenization method: Preparation, characterization, and pharmacokinetic evaluation. Journal of Drug Delivery Science and Technology, 53, 101185. https://doi.org/10.1016/j.jddst.2019.101185
  • Fang, C. L. A., Al-Suwayeh, S., & Fang, J. Y. (2013). Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Patents on Nanotechnology, 7(1), 41–55. https://doi.org/10.2174/187221013804484827
  • Freitas, C., & Müller, R. H. (1998). Spray-drying of solid lipid nanoparticles (SLN™). European Journal of Pharmaceutics and Biopharmaceutics, 46(2), 145–151. https://doi.org/10.1016/S0939-6411(97)00172-0
  • Gasco, M. R. (2009). Use of solid lipid nanoparticles comprising cholesteryl propionate and/or cholesteryl butyrate (U.S. Patent Application No. 11/921,634).
  • Ghosh, S. K., Kundu, S., & Pal, T. (2002). Evolution, dissolution and reversible generation of gold and silver nanoclusters in micelle by UV-activation. Bulletin of Materials Science, 25(6), 581–582. https://doi.org/10.1007/BF02710556
  • Gill, P., Moghadam, T. T., & Ranjbar, B. (2010). Differential scanning calorimetry techniques: Applications in biology and nanoscience. Journal of Biomolecular Techniques, 21(4), 167–193. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2977967/
  • Goyal, S., Thirumal, D., Rana, J., Gupta, A. K., Kumar, A., Babu, M. A., Kumar, P., & Sindhu, R. K. (2024). Chitosan-based nanocarriers as a promising tool in treatment and management of inflammatory diseases. Carbohydrate Polymer Technologies and Applications, 7, 100442. https://doi.org/10.1016/j.carpta.2024.100442
  • Hayashi, H., & Hakuta, Y. (2010). Hydrothermal synthesis of metal oxide nanoparticles in supercritical water. Materials, 3(7), 3794–3817. https://doi.org/10.3390/ma3073794
  • Heppner, A. F., Hansen, P., & Schumann, C. (2007). Sunscreen preparations comprising solid lipid nanoparticles (DE Patent 61197).
  • Heurtault, B., Saulnier, P., Pech, B., Proust, J. E., & Benoit, J. P. (2002). A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharmaceutical Research, 19(6), 875–880. https://doi.org/10.1023/A:1016121319668
  • Hu, Y., Gong, M., Feng, S., Xu, C. C., & Bassi, A. (2019). A review of recent developments of pre-treatment technologies and hydrothermal liquefaction of microalgae for bio-crude oil production. Renewable and Sustainable Energy Reviews, 101, 476–492. https://doi.org/10.1016/j.rser.2018.11.037
  • Iqbal, M., Zafar, N., Fessi, H., & Elaissari, A. (2015). Double emulsion solvent evaporation techniques used for drug encapsulation. International Journal of Pharmaceutics, 496(2), 173–190. https://doi.org/10.1016/j.ijpharm.2015.10.057
  • Jenning, V., Gysler, A., Schäfer-Korting, M., & Gohla, S. H. (2000). Vitamin A-loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. European Journal of Pharmaceutics and Biopharmaceutics, 49(3), 211–218. https://doi.org/10.1016/S0939-6411(99)00075-2
  • Jeong, S. Y., Kwon, I. C., & Chung, H. (2000). Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier (PCT International Application No. WO 2000006120).
  • Jores, K., Mehnert, W., & Mäder, K. (2003). Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: A nuclear magnetic and electron spin resonance study. Pharmaceutical Research, 20(8), 1274–1283. https://link.springer.com/article/10.1023/A:1025065418309
  • Joshi, M., & Patravale, V. (2006). Formulation and evaluation of nanostructured lipid carrier (NLC)-based gel of Valdecoxib. Drug Development and Industrial Pharmacy, 32(8), 911–918. https://doi.org/10.1080/03639040600814676
  • Junyaprasert, V. B., Teeranachaideekul, V., Souto, E. B., Boonme, P., & Müller, R. H. (2009). Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation. International Journal of Pharmaceutics, 377(1–2), 207–214. https://doi.org/10.1016/j.ijpharm.2009.05.020
  • Kaur, I. P., & Bhandari, R. (2012). Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and a process for preparing the same (PCT Application No. PCT/IN2012/000154).
  • Klang, V., Matsko, N. B., Valenta, C., & Hofer, F. (2012). Electron microscopy of nanoemulsions: An essential tool for characterization and stability assessment. Micron, 43(2–3), 85–103. https://doi.org/10.1016/j.micron.2011.07.014
  • Lekka, M., Pogoda, K., Gostek, J., Klymenko, O., Prauzner-Bechcicki, S., Wiltowska-Zuber, J., Jaczewska, J., Lekki, J., & Stachura, Z. (2012). Cancer cell recognition–mechanical phenotype. Micron, 43(12), 1259–1266. https://doi.org/10.1016/j.micron.2012.01.019
  • Li, C., Zhou, K., Chen, D., Xu, W., Tao, Y., Pan, Y., Meng, K., Shabbir, M. A., Liu, Q., Huang, L., & Xie, S. (2019). Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin. International Journal of Nanomedicine, 14, 1619–1631. https://doi.org/10.2147/IJN.S183479
  • Li, Z., Li, X. W., Zheng, L. Q., Lin, X. H., Geng, F., & Yu, L. (2010). Bovine serum albumin-loaded solid lipid nanoparticles prepared by double emulsion method. Chemical Research in Chinese Universities, 26(1), 136–141.
  • Lopes, C. P. A. (2014). Development and characterization of lipid nanoparticles prepared by mini-emulsion technique (Doctoral dissertation, University of Lisbon, Portugal).
  • Malamatari, M., Charisi, A., Malamataris, S., Kachrimanis, K., & Nikolakakis, I. (2020). Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation. Processes, 8(7), 788–814. https://doi.org/10.3390/pr8070788
  • Mishra, H., Mishra, D., Mishra, P. K., Nahar, M., Dubey, V., & Jain, D. K. (2010). Evaluation of solid lipid nanoparticles as carriers for delivery of Hepatitis B surface antigen for vaccination using the subcutaneous route. Journal of Pharmacy & Pharmaceutical Sciences, 13(4), 495–509. https://doi.org/10.18433/J3XK53
  • Mohanty, U. S. (2011). Electrodeposition: A versatile and inexpensive tool for the synthesis of nanoparticles, nanorods, nanowires, and nanoclusters of metals. Journal of Applied Electrochemistry, 41(3), 257–270. https://doi.org/10.1007/s10800-010-0234-3
  • Montenegro, L., Sinico, C., Castangia, I., Carbone, C., & Puglisi, G. (2012). Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: In vitro evaluation. International Journal of Pharmaceutics, 434(1–2), 169–174. https://doi.org/10.1016/j.ijpharm.2012.05.046
  • Mukherjee, S., Ray, S., & Thakur, R. S. (2009). Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian Journal of Pharmaceutical Sciences, 71(4), 349–358. https://doi.org/10.4103/0250-474X.57282
  • Müller, R., Maaben, S., Weyhers, H., & Mehnert, W. (1996). Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. Journal of Drug Targeting, 4(3), 161–170. https://doi.org/10.3109/10611869609015973
  • Nabi-Meibodi, M., Vatanara, A., Najafabadi, A. R., Rouini, M. R., Ramezani, V., Gilani, K., Etemadzadeh, S. M. H., & Azadmanesh, K. (2013). The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Colloids and Surfaces B: Biointerfaces, 112, 408–414. https://doi.org/10.1016/j.colsurfb.2013.06.013
  • Nair, A. B., Shah, J., Al-Dhubiab, B. E., Jacob, S., Patel, S. S., Venugopala, K. N., … & Shinu, P. (2021). Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation, and in vivo studies. Pharmaceutics, 13(4), 523. https://doi.org/10.3390/pharmaceutics13040523
  • Naseri, M., Golmohamadzadeh, S., Arouiee, H., Jaafari, M. R., & Nemati, S. H. (2020). Preparation and comparison of various formulations of solid lipid nanoparticles (SLNs) containing essential oil of Zataria multiflora. Horticulture and Postharvest Research, 3(1), 73–84. https://doi.org/10.22077/jhpr.2019.2570.1068
  • Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015). Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Advanced Pharmaceutical Bulletin, 5(3), 305–313. https://doi.org/10.15171/apb.2015.043
  • Noriega-Peláez, E. K., Mendoza-Muñoz, N., Ganem-Quintanar, A., & Quintanar-Guerrero, D. (2011). Optimization of the emulsification and solvent displacement method for the preparation of solid lipid nanoparticles. Drug Development and Industrial Pharmacy, 37(2), 160–166. https://doi.org/10.3109/03639045.2010.501800
  • Olbrich, C., Kayser, O., & Müller, R. H. (2002). Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN): Effect of surfactants, storage time and crystallinity. International Journal of Pharmaceutics, 237(1–2), 119–128.
  • Pardeike, J., Hommoss, A., & Müller, R. H. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. International Journal of Pharmaceutics, 366(1–2), 170–184. https://doi.org/10.1016/j.ijpharm.2008.10.003
  • Patel, H., Manocha, L. M., & Manocha, S. (2012). Large-scale synthesis of carbon nanotubes from liquefied petroleum gas on Fe/MgO and Fe-Ni/MgO. Nanoscience & Nanotechnology-Asia, 2(1), 66–75. https://doi.org/10.2174/2210681211202010066
  • Patel, M. H., Mundada, V. P., & Sawant, K. K. (2019). Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: Optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug Development and Industrial Pharmacy, 45(8), 1242–1257. https://doi.org/10.1080/03639045.2019.1593434
  • Patil, J., Gurav, P., Kulkarni, R., Jadhav, S., Mandave, S., Shete, M., & Chipade, V. (2013). Applications of solid lipid nanoparticles in novel drug delivery system. British Biomedical Bulletin, 1(2), 103–118.
  • Pérez-Tijerina, E., Pinilla, M. G., Mejía-Rosales, S., Ortiz-Méndez, U., Torres, A., & José-Yacamán, M. (2008). Highly size-controlled synthesis of Au/Pd nanoparticles by inert-gas condensation. Faraday Discussions, 138, 353–362. https://doi.org/10.1039/B705913M
  • Puglia, C., Blasi, P., Rizza, L., Schoubben, A., Bonina, F., Rossi, C., & Ricci, M. (2008). Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation. International Journal of Pharmaceutics, 357(1–2), 295–304. https://doi.org/10.1016/j.ijpharm.2008.01.045
  • Quintanar-Guerrero, D., Tamay Esquivel, D., Ganem Quintanar, A., Allemann, E., & Doelker, E. (2005). Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. European Journal of Pharmaceutical Sciences, 26(2), 211–218. https://doi.org/10.1016/j.ejps.2005.06.001
  • Reddy, R. N., & Shariff, A. (2013). Solid lipid nanoparticles: An advanced drug delivery system. International Journal of Pharmaceutical Sciences and Research, 4(1), 161–171. https://doi.org/10.13040/IJPSR.0975-8232.4(1).161-71
  • Roy, N., Agrawal, M., Chaudhary, S., Tirkey, V., Dhwaj, A., & Mishra, N. (2017). Review article on permeation enhancers: A major breakthrough in drug delivery technology. International Journal of Pharmaceutical Sciences and Research, 8(3), 1001–1011. https://doi.org/10.13040/IJPSR.0975-8232.8(3).1001-11
  • Saharan, A., Verma, I., Dhanawat, M., & Parkash, C. (2024). Nano-Drug Delivery Systems in the Treatment of Wound Healing. In Nanotechnology and Drug Delivery (pp. 439-467). Jenny Stanford Publishing.
  • Salvi, V. R., & Pawar, P. (2019). Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology, 51, 255–267. https://doi.org/10.1016/j.jddst.2019.02.017
  • Severino, P., Andreani, T., Macedo, A. S., Fangueiro, J. F., Santana, M. H. A., Silva, A. M., & Souto, E. B. (2012). Current state-of-the-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. Journal of Drug Delivery, 2012, 1–10. https://doi.org/10.1155/2012/750891
  • Shah, K. A., Date, A. A., Joshi, M. D., & Patravale, V. B. (2007). Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. International Journal of Pharmaceutics, 345(1–2), 163–171. https://doi.org/10.1016/j.ijpharm.2007.05.061
  • Shastri, V., Sussman, E., & Jayagopal, A. (2006). Functionalized solid lipid nanoparticles and methods of making and using same (U.S. Patent Application No. 11/251,109).
  • Shelake, S., Patil, S., Patil, S., & Sangave, P. (2018). Formulation and evaluation of fenofibrate-loaded nanoparticles by precipitation method. Indian Journal of Pharmaceutical Sciences, 80(3), 420–427. https://doi.org/10.4172/pharmaceutical-sciences.1000374
  • Shen, J., Wang, Y., Ping, Q., Xiao, Y., & Huang, X. (2009). Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. Journal of Controlled Release, 137(3), 217–223. https://doi.org/10.1016/j.jconrel.2009.04.021
  • Siekmann, B., & Westesen, K. (1996). Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. European Journal of Pharmaceutics and Biopharmaceutics, 42(2), 104–109.
  • Singh, R., & Lillard, J. W., Jr. (2009). Nanoparticle-based targeted drug delivery. Experimental and Molecular Pathology, 86(3), 215–223. https://doi.org/10.1016/j.yexmp.2008.12.004
  • Sjöström, B., & Bergenståhl, B. (1992). Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. International Journal of Pharmaceutics, 88, 53–62. https://doi.org/10.1016/0378-5173(92)90303-J
  • Sonawane, R. S., & Dongare, M. K. (2006). Sol–gel synthesis of Au/TiO₂ thin films for photocatalytic degradation of phenol in sunlight. Journal of Molecular Catalysis A: Chemical, 243(1), 68–77. https://doi.org/10.1016/j.molcata.2005.07.043
  • Song, K. C., Lee, S. M., Park, T. S., & Lee, B. S. (2009). Preparation of colloidal silver nanoparticles by chemical reduction method. Korean Journal of Chemical Engineering, 26(1), 153–155. https://doi.org/10.1007/s11814-009-0024-y
  • Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmaceutics, 278(1), 71–77. https://doi.org/10.1016/j.ijpharm.2004.02.032
  • Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmaceutics, 278(1), 71–77. https://doi.org/10.1016/j.ijpharm.2004.02.032
  • Tamjidi, F., Shahedi, M., Varshosaz, J., & Nasirpour, A. (2013). Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innovative Food Science & Emerging Technologies, 19, 29–43. https://doi.org/10.1016/j.ifset.2013.03.002
  • Teeranachaideekul, V., Boonme, P., Souto, E. B., Müller, R., & Junyaprasert, V. B. (2008). Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. Journal of Controlled Release, 128(2), 134–141. https://doi.org/10.1016/j.jconrel.2008.02.011
  • Tsai, M. J., Wu, P. C., Huang, Y. B., Chang, J. S., Lin, C. L., Tsai, Y. H., & Fang, J. Y. (2012). Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. International Journal of Pharmaceutics, 423(2), 461–470. https://doi.org/10.1016/j.ijpharm.2011.12.009
  • Ueda, M., & Kreuter, J. (1997). Optimization of the preparation of loperamide-loaded poly(L-lactide) nanoparticles by high-pressure emulsification-solvent evaporation. Journal of Microencapsulation, 14(5), 593–605. https://doi.org/10.3109/02652049709006812
  • Umeyor, C. E., Negi, P., Ezegbe, A., Bairagi, G., & Patravale, V. B. (2026). Stimuli-responsive lipid nanoparticles for cancer therapy. In Advances in Stimuli-Responsive Nanosystems for Cancer Therapy (pp. 147–180). Springer Nature Singapore. https://doi.org/10.1007/978-981-95-2744-1_7
  • Venkateswarlu, V., & Manjunath, K. (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Journal of Controlled Release, 95(3), 627–638. https://doi.org/10.1016/j.jconrel.2004.01.005
  • Viladot Petit, J. L., Delgado González, R., & Fernández Botello, A. (2011). Lipid nanoparticle capsules (WO Patent No. 2011116963).
  • Wai, C. M., & Wang, S. (1997). Supercritical fluid extraction: Metals as complexes. Journal of Chromatography A, 785(1–2), 369–383. https://doi.org/10.1016/S0021-9673(97)00679-1
  • Westesen, K., & Siekmann, B. (1997). Solid lipid particles, particles of bioactive agents and methods for the manufacture and use (U.S. Patent No. 5,785,976).
  • Wilson, B., & Geetha, K. M. (2022). Lipid nanoparticles in the development of mRNA vaccines for COVID-19. Journal of Drug Delivery Science and Technology, 74, 103553. https://doi.org/10.1016/j.jddst.2022.103553
  • Wissing, S. A., & Müller, R. H. (2003). The influence of solid lipid nanoparticles on skin hydration and viscoelasticity: In vivo study. European Journal of Pharmaceutics and Biopharmaceutics, 56(1), 67–72. https://doi.org/10.1016/S0939-6411(03)00040-7
  • Wissing, S. A., Kayser, O., & Müller, R. H. (2004). Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews, 56(9), 1257–1272. https://doi.org/10.1016/j.addr.2003.12.002
  • Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., El-Bagory, I. M., Bayomi, M. A., & Alsarra, I. A. (2010). Optimization of 5-fluorouracil solid lipid nanoparticles: A preliminary study to treat colon cancer. International Journal of Medical Sciences, 7(6), 398–408. https://doi.org/10.7150/ijms.7.398
  • Zhang, Q., Yang, H., Sahito, B., Li, X., Peng, L., Gao, X., Ji, H., Wang, L., Jiang, S., & Guo, D. (2020). Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. Colloids and Surfaces B: Biointerfaces, 187, 110649. https://doi.org/10.1016/j.colsurfb.2019.110649
  • Zhang, X., Zhang, H., Wu, Z., Wang, Z., Niu, H., Li, C., & Liu, Q. (2008). Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 68(3), 526–534. https://doi.org/10.1016/j.ejpb.2007.08.009

How to Cite

Ravi Goyal, Gurpreet Kaur, Sumit Sharma, Deepika Raina, Nitin Chitranshi. Comprehensive Insights into Lipid Nanocarriers: Preparation, Characterization and Applications. J. Pharm. Technol. Res. Manag.. 2026, 13, 88-107
Comprehensive Insights into Lipid Nanocarriers: Preparation, Characterization and Applications

Current Issue

PeriodicityBiannually
Issue-1June
Issue-2December
ISSN Print2321-2217
ISSN Online2321-2225
RNI No.CHAENG/2013/50088

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Pharmaceutical Technology, Research and Management (J. Pharm. Tech. Res. Management) by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jptrm.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/

Creative Commons License

Journal of Pharmaceutical Technology, Research and Management by Chitkara University Publications is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://jptrm.chitkara.edu.in//

Visibility, Memberships and Ethics

Chitkara University

Chitkara University

India’s top rated university

Chandigarh-Patiala National Highway, Punjab 140 401

Chandigarh Information Center SCO 160-161, Sector 9-C, Chandigarh 160 009

Publisher

Corporate Office

Chitkara University Publications
Administrative Office, Saraswati Kendra
P.O. Box No. 70,
SCO 160-161, Sector- 9C, Chandigarh-160009, India.

Email: chitkarauniversitypublications@chitkara.edu.in

Editorial Office

Centre for Research Impact and Outcome
4th floor, Darwin Block
Chandigarh-Patiala National Highway, Rajpura
Punjab-140401, India
Email: editor.jptrm@chitkara.edu.in, journals@chitkara.edu.in

For journal please visit the website: https://jptrm.chitkara.edu.in/

The "Journal of Pharmaceutical Technology, Research and Management” is a peer-reviewed, refereed, bi-annual open-access Journal of "Chitkara University Publications".

ISSN (p): 2321-2217 ; ISSN (e): 2321-2225 ; RNI No: CHAENG/2013/50088

Copyright ©2023 Chitkara Educational Trust | All rights reserved
Explore Your Potential

Chandigarh-Patiala National Highway, Punjab 140 401

Chandigarh Information Center SCO 160-161, Sector 9-C, Chandigarh 160 009

×
✔

Thank You!

Your form has been submitted successfully.